[go: up one dir, main page]

EP1859063A4 - Replikin peptides and uses thereof - Google Patents

Replikin peptides and uses thereof

Info

Publication number
EP1859063A4
EP1859063A4 EP06735145A EP06735145A EP1859063A4 EP 1859063 A4 EP1859063 A4 EP 1859063A4 EP 06735145 A EP06735145 A EP 06735145A EP 06735145 A EP06735145 A EP 06735145A EP 1859063 A4 EP1859063 A4 EP 1859063A4
Authority
EP
European Patent Office
Prior art keywords
replikin peptides
replikin
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06735145A
Other languages
German (de)
French (fr)
Other versions
EP1859063A2 (en
Inventor
Samuel Dr Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by Individual filed Critical Individual
Publication of EP1859063A2 publication Critical patent/EP1859063A2/en
Publication of EP1859063A4 publication Critical patent/EP1859063A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
EP06735145A 2005-02-16 2006-02-16 Replikin peptides and uses thereof Withdrawn EP1859063A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Publications (2)

Publication Number Publication Date
EP1859063A2 EP1859063A2 (en) 2007-11-28
EP1859063A4 true EP1859063A4 (en) 2012-02-01

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06735145A Withdrawn EP1859063A4 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Country Status (8)

Country Link
EP (1) EP1859063A4 (en)
JP (1) JP2008539164A (en)
AU (1) AU2006214332B2 (en)
CA (1) CA2598381A1 (en)
IL (1) IL185308A0 (en)
NZ (1) NZ560415A (en)
SG (1) SG160327A1 (en)
WO (1) WO2006088962A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2027146B1 (en) * 2006-05-30 2012-10-03 Bogoch, Samuel, Dr. Replikin peptides and uses thereof
EP2092059A4 (en) * 2006-10-24 2012-03-28 Bogoch Samuel A method of predicting influenza outbreaks
WO2008143717A2 (en) 2007-01-18 2008-11-27 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
CN101969993B (en) 2007-05-30 2013-10-16 塞缪尔·博戈奇 Synthetic Replikin Peptides Against Pathogen Infection of Invertebrates in Aquaculture
CA2720465A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
WO2010017514A2 (en) * 2008-08-08 2010-02-11 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
WO2010123519A1 (en) * 2009-04-23 2010-10-28 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
AU2012283914A1 (en) 2011-07-20 2014-01-30 Bogoch, Elanore S. Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
SG11201405447QA (en) 2012-03-09 2014-10-30 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151677A1 (en) * 2001-03-27 2002-10-17 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (en) 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151677A1 (en) * 2001-03-27 2002-10-17 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOGOCH S, BOGOCH ES: "Rapid replication and Replikintm structures: basis of the AMASRTest and CAVAXR.", CANCER DETECTION AND PREVENTION ONLINE, 9 February 2002 (2002-02-09), XP002350483 *
See also references of WO2006088962A2 *

Also Published As

Publication number Publication date
EP1859063A2 (en) 2007-11-28
NZ560415A (en) 2010-05-28
IL185308A0 (en) 2008-02-09
AU2006214332B2 (en) 2012-03-22
JP2008539164A (en) 2008-11-13
CA2598381A1 (en) 2006-08-24
AU2006214332A1 (en) 2006-08-24
WO2006088962A2 (en) 2006-08-24
WO2006088962A9 (en) 2006-11-16
SG160327A1 (en) 2010-04-29
WO2006088962A3 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
EP1920216A4 (en) Location signposting and orientation
IL228770A0 (en) Processes and intermaediates
IL222922A (en) Anti-neuropilin-1 antibodies and uses thereof
EP1976864A4 (en) Novel peptide and use thereof
IL184428A0 (en) Peptides with neuropeptide-2-receptor
IL185308A0 (en) Replikin peptides and uses thereof
IL187617A0 (en) Lkktet and/or lkktnt peptide compositions and methods
IL179497A0 (en) Carboranylporphyrins and uses thereof
GB0508863D0 (en) Peptide
IL195525A0 (en) Replikin peptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
IL180365A0 (en) Carboranylporphyrins and uses thereof
ZA200801874B (en) Antigenic peptides and their use
EP1953227A4 (en) Lipopolysaccharide- or lipid a-binder, and novel peptide
GB0517293D0 (en) Vectors and uses thereof
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0617564D0 (en) Peptides and methods
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0516571D0 (en) Novel polypeptides and uses thereof
GB0517813D0 (en) Peptides and uses thereof
EP1910405A4 (en) Complement c3a derived peptides and uses thereof
GB0612873D0 (en) Isolated peptides and uses thereof
GB0425731D0 (en) Isolated peptides and uses thereof
GB0503093D0 (en) Ricin-binding peptide and methods for use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070912

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

R17D Deferred search report published (corrected)

Effective date: 20080124

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1116833

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20111230

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALN20111223BHEP

Ipc: C07K 14/11 20060101ALN20111223BHEP

Ipc: C07K 16/10 20060101ALI20111223BHEP

Ipc: G01N 33/50 20060101ALI20111223BHEP

Ipc: G06F 17/00 20060101ALI20111223BHEP

Ipc: G06F 19/00 20110101AFI20111223BHEP

17Q First examination report despatched

Effective date: 20120113

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1116833

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150901